123 related articles for article (PubMed ID: 33882792)
1. Feasibility of palliating recurrent gynecological tumors with MRGHIFU: comparison of symptom, quality-of-life, and imaging response in intra and extra-pelvic disease.
Imseeh G; Giles SL; Taylor A; Brown MRD; Rivens I; Gordon-Williams R; Ter Haar G; deSouza NM
Int J Hyperthermia; 2021; 38(1):623-632. PubMed ID: 33882792
[TBL] [Abstract][Full Text] [Related]
2. Comparison of Imaging Changes and Pain Responses in Patients with Intra- or Extraosseous Bone Metastases Treated Palliatively with Magnetic Resonance-Guided High-Intensity-Focused Ultrasound.
Giles SL; Brown MRD; Rivens I; Deppe M; Huisman M; Kim YS; Farquhar-Smith P; Williams JE; Ter Haar GR; deSouza NM
J Vasc Interv Radiol; 2019 Sep; 30(9):1351-1360.e1. PubMed ID: 31101417
[TBL] [Abstract][Full Text] [Related]
3. Prediction of pelvic tumour coverage by magnetic resonance-guided high-intensity focused ultrasound (MRgHIFU) from referral imaging.
Lam NFD; Rivens I; Giles SL; Harris E; deSouza NM; Ter Haar G
Int J Hyperthermia; 2020; 37(1):1033-1045. PubMed ID: 32873089
[TBL] [Abstract][Full Text] [Related]
4. MR guided high intensity focused ultrasound (MRgHIFU) for treating recurrent gynaecological tumours: a pilot feasibility study.
Giles SL; Imseeh G; Rivens I; Ter Haar GR; Taylor A; deSouza NM
Br J Radiol; 2019 Jun; 92(1098):20181037. PubMed ID: 31084495
[TBL] [Abstract][Full Text] [Related]
5. Efficacy, Efficiency, and Safety of Magnetic Resonance-Guided High-Intensity Focused Ultrasound for Ablation of Uterine Fibroids: Comparison with Ultrasound-Guided Method.
Wang Y; Wang ZB; Xu YH
Korean J Radiol; 2018; 19(4):724-732. PubMed ID: 29962878
[TBL] [Abstract][Full Text] [Related]
6. Feasibility and safety assessment of magnetic resonance-guided high-intensity focused ultrasound (MRgHIFU)-mediated mild hyperthermia in pelvic targets evaluated using an
Zhu L; Partanen A; Talcott MR; Gach HM; Greco SC; Henke LE; Contreras JA; Zoberi I; Hallahan DE; Chen H; Altman MB
Int J Hyperthermia; 2019; 36(1):1147-1159. PubMed ID: 31752562
[No Abstract] [Full Text] [Related]
7. MR-guided focused ultrasound therapy of extra-abdominal desmoid tumors: a multicenter retrospective study of 105 patients.
Düx DM; Baal JD; Bitton R; Chen J; Brunsing RL; Sheth VR; Rosenberg J; Kim K; Ozhinsky E; Avedian R; Ganjoo K; Bucknor M; Dobrotwir A; Ghanouni P
Eur Radiol; 2024 Feb; 34(2):1137-1145. PubMed ID: 37615768
[TBL] [Abstract][Full Text] [Related]
8. High-intensity focused ultrasound ablation in the treatment of recurrent ovary cancer and metastatic pelvic tumors: a feasibility study.
Lei T; Guo X; Gong C; Chen X; Ran F; He Y; Shi Q; He J
Int J Hyperthermia; 2021; 38(1):282-287. PubMed ID: 33612045
[TBL] [Abstract][Full Text] [Related]
9. Quantitative prediction of the extent of pelvic tumour ablation by magnetic resonance-guided high intensity focused ultrasound.
Lam NFD; Rivens I; Giles SL; Harris E; deSouza NM; Ter Haar G
Int J Hyperthermia; 2021; 38(1):1111-1125. PubMed ID: 34325608
[TBL] [Abstract][Full Text] [Related]
10. Targetability of osteoid osteomas and bone metastases by MR-guided high intensity focused ultrasound (MRgHIFU).
Bing F; Vappou J; de Mathelin M; Gangi A
Int J Hyperthermia; 2018; 35(1):471-479. PubMed ID: 30208747
[TBL] [Abstract][Full Text] [Related]
11. Pilot Study of the Mirabilis System Prototype for Rapid Noninvasive Uterine Myoma Treatment Using an Ultrasound-Guided Volumetric Shell Ablation Technique.
Parsons JE; Lau MPH; Martin PJ; Islas Lagos JJ; Aguilar Aguirre JM; Garza Leal JG
J Minim Invasive Gynecol; 2017; 24(4):579-591. PubMed ID: 28109895
[TBL] [Abstract][Full Text] [Related]
12. Magnetic Resonance-guided High-intensity Focused Ultrasound (MRgHIFU) Virtual Treatment Planning for Abdominal Neuroblastoma Utilizing Retrospective Diagnostic 3D CT Images.
Tung S; Fahy AS; Lamberti-Pasculli M; Waspe AC; Pichardo S; Gerstle JT
J Pediatr Hematol Oncol; 2019 Oct; 41(7):e443-e449. PubMed ID: 31449496
[TBL] [Abstract][Full Text] [Related]
13. Magnetic resonance-guided focused ultrasound treatment of extra-abdominal desmoid tumors: a retrospective multicenter study.
Ghanouni P; Dobrotwir A; Bazzocchi A; Bucknor M; Bitton R; Rosenberg J; Telischak K; Busacca M; Ferrari S; Albisinni U; Walters S; Gold G; Ganjoo K; Napoli A; Pauly KB; Avedian R
Eur Radiol; 2017 Feb; 27(2):732-740. PubMed ID: 27147222
[TBL] [Abstract][Full Text] [Related]
14. Urinary cytokines/chemokines after magnetic resonance-guided high intensity focused ultrasound for palliative treatment of painful bone metastases.
Bushehri A; Czarnota G; Zhang L; Hynynen K; Huang Y; Chan M; Chu W; Dennis K; Mougenot C; Coccagna J; Sahgal A; Chow E; DeAngelis C
Ann Palliat Med; 2017 Jan; 6(1):36-54. PubMed ID: 28209068
[TBL] [Abstract][Full Text] [Related]
15. Mid-term efficacy grading evaluation and predictive factors of magnetic resonance-guided focused ultrasound surgery for painful bone metastases: a multi-center study.
Yin X; Tang N; Fan X; Wang S; Zhang J; Gu J; Wang H
Eur Radiol; 2023 Feb; 33(2):1465-1474. PubMed ID: 36074263
[TBL] [Abstract][Full Text] [Related]
16. Ultrasound-Guided High Intensity Focused Ultrasound Ablation for Symptomatic Uterine Fibroids: Preliminary Clinical Experience.
Lyon PC; Rai V; Price N; Shah A; Wu F; Cranston D
Ultraschall Med; 2020 Oct; 41(5):550-556. PubMed ID: 31238385
[TBL] [Abstract][Full Text] [Related]
17. Three-dimensional quantitative assessment of lesion response to MR-guided high-intensity focused ultrasound treatment of uterine fibroids.
Savic LJ; Lin MD; Duran R; Schernthaner RE; Hamm B; Geschwind JF; Hong K; Chapiro J
Acad Radiol; 2015 Sep; 22(9):1199-205. PubMed ID: 26160057
[TBL] [Abstract][Full Text] [Related]
18. What predicts durable symptom relief of uterine fibroids treated with MRI-guided focused ultrasound? A multicenter trial in 8 academic centers.
Bitton RR; Fast A; Vu KN; Lum DA; Chen B; Hesley GK; Raman SS; Matsumoto AH; Price TM; Tempany C; Dhawan N; Dolen E; Kohi M; Fennessey FM; Ghanouni P
Eur Radiol; 2023 Nov; 33(11):7360-7370. PubMed ID: 37553488
[TBL] [Abstract][Full Text] [Related]
19. A feasibility analysis of the ArcBlate MR-guided high-intensity focused ultrasound system for the ablation of uterine fibroids.
Wang CJ; Lin G; Huang YT; Weng CH; Wu KY; Su YY; Lin YS; Mak KS
Abdom Radiol (NY); 2021 Nov; 46(11):5307-5315. PubMed ID: 34241647
[TBL] [Abstract][Full Text] [Related]
20. Magnetic Resonance-Guided High-Intensity Focused Ultrasound (MRgHIFU) for Treatment of Symptomatic Uterine Fibroids: An Economic Analysis.
Babashov V; Palimaka S; Blackhouse G; O'Reilly D
Ont Health Technol Assess Ser; 2015; 15(5):1-61. PubMed ID: 26357531
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
